FDA Issues Urgent Nationwide Recall for a Widely Used Medication After Discovery of Dangerous Cancer-Causing Chemical

The U.S. Food and Drug Administration has issued a voluntary recall of Chantix after testing found elevated nitrosamine levels in some batches.

Officials said the levels exceeded safety limits, prompting precautionary action with the manufacturer. Nitrosamines are compounds linked to potential cancer risk at high exposure levels.

The FDA stressed that patients should not panic but should consult healthcare providers about alternatives while the issue is being addressed.